Active Ingredient(s): Polythiazide + Prazosin
FDA Approved: * June 13, 1980
Pharm Company: * PFIZER
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Minizide Overview

Prazosin is an alpha-1 blocker medication primarily used to treat high blood pressure, symptoms of an enlarged prostate, and posttraumatic stress disorder (PTSD).[4] It is a less preferred treatment of high blood pressure.[4] Other uses may include heart failure and Raynaud syndrome.[5] It is taken by mouth.[4] Common side effects include dizziness, sleepiness, nausea, and heart palpitations.[4] Serious side effec...

Read more Minizide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Minizide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Polythiazide + Prazosin
  • Capsule: 0.5mg + 1mg, 0.5mg + 2mg, 0.5mg + 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Minizide: (3 results)

Sorted by National Drug Code
  • 0069-4300 Minizide 1 Oral Capsule by Pfizer Labs
  • 0069-4320 Minizide 2 Oral Capsule by Pfizer Labs
  • 0069-4360 Minizide 5 Oral Capsule by Pfizer Labs

Drugs with one or more similar ingredients: (5 results)